{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:30:48Z","timestamp":1787002248625,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T00:00:00Z","timestamp":1490832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T00:00:00Z","timestamp":1490832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2017,5,9]]},"DOI":"10.1038\/bjc.2017.86","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T18:47:29Z","timestamp":1490899649000},"page":"1294-1301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma\u2014experience of the BriTROC consortium"],"prefix":"10.1038","volume":"116","author":[{"name":"on behalf of the BriTROC investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Goranova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Piskorz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L A","family":"Lewsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Stobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R M","family":"Glasspool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lockley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Brockbank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Edmondson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G D","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Clamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Gourley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Fotopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Gabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Jimenez-Linan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J D","family":"Brenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I A","family":"McNeish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,30]]},"reference":[{"issue":"17","key":"BFbjc201786_CR1","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1200\/JCO.2012.42.0505","volume":"30","author":"C Aghajanian","year":"2012","unstructured":"Aghajanian C, Blank SV, Goff BA, Judson PL, Teneriello MG, Husain A, Sovak MA, Yi J, Nycum LR (2012) OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol 30 (17): 2039\u20132045.","journal-title":"J Clin Oncol"},{"issue":"1","key":"BFbjc201786_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/path.2696","volume":"221","author":"AA Ahmed","year":"2010","unstructured":"Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, Stewart C, Fereday S, Caldas C, Defazio A, Bowtell D, Brenton JD (2010) Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol 221 (1): 49\u201356.","journal-title":"J Pathol"},{"issue":"5","key":"BFbjc201786_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2 (5): 401\u2013404.","journal-title":"Cancer Discov"},{"issue":"7182","key":"BFbjc201786_CR4","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/nature06548","volume":"451","author":"SL Edwards","year":"2008","unstructured":"Edwards SL, Brough R, Lord CJ, Natrajan R, Vatcheva R, Levine DA, Boyd J, Reis-Filho JS, Ashworth A (2008) Resistance to therapy caused by intragenic deletion in BRCA2. Nature 451 (7182): 1111\u20131115.","journal-title":"Nature"},{"issue":"9","key":"BFbjc201786_CR5","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1634\/theoncologist.2011-0043","volume":"16","author":"H El-Osta","year":"2011","unstructured":"El-Osta H, Hong D, Wheler J, Fu S, Naing A, Falchook G, Hicks M, Wen S, Tsimberidou AM, Kurzrock R (2011) Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience. Oncologist 16 (9): 1292\u20131298.","journal-title":"Oncologist"},{"issue":"136","key":"BFbjc201786_CR6","doi-asserted-by":"publisher","first-page":"136ra68","DOI":"10.1126\/scitranslmed.3003726","volume":"4","author":"T Forshew","year":"2012","unstructured":"Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DW, Kaper F, Dawson SJ, Piskorz AM, Jimenez-Linan M, Bentley D, Hadfield J, May AP, Caldas C, Brenton JD, Rosenfeld N (2012) Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med 4 (136): 136ra68.","journal-title":"Sci Transl Med"},{"issue":"4","key":"BFbjc201786_CR7","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/bjc.2013.417","volume":"109","author":"GA Freeman","year":"2013","unstructured":"Freeman GA, Kimmelman J, Dancey J, Monzon JG (2013) Reporting practices of pharmacodynamic studies involving invasive research procedures in cancer trials. Br J Cancer 109 (4): 897\u2013908.","journal-title":"Br J Cancer"},{"issue":"269","key":"BFbjc201786_CR8","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6 (269): pl1.","journal-title":"Sci Signal"},{"issue":"5","key":"BFbjc201786_CR9","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/annonc\/mdr383","volume":"23","author":"CA Gomez-Roca","year":"2012","unstructured":"Gomez-Roca CA, Lacroix L, Massard C, De Baere T, Deschamps F, Pramod R, Bahleda R, Deutsch E, Bourgier C, Angevin E, Lazar V, Ribrag V, Koscielny S, Chami L, Lassau N, Dromain C, Robert C, Routier E, Armand JP, Soria JC (2012) Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety. Ann Oncol 23 (5): 1301\u20131306.","journal-title":"Ann Oncol"},{"issue":"9","key":"BFbjc201786_CR10","doi-asserted-by":"publisher","first-page":"pii: e11408","DOI":"10.1371\/journal.pone.0011408","volume":"5","author":"KL Gorringe","year":"2010","unstructured":"Gorringe KL, George J, Anglesio MS, Ramakrishna M, Etemadmoghadam D, Cowin P, Sridhar A, Williams LH, Boyle SE, Yanaihara N, Okamoto A, Urashima M, Smyth GK, Campbell IG, Bowtell DD Australian Ovarian Cancer S (2010) Copy number analysis identifies novel interactions between genomic loci in ovarian cancer. PLoS One 5 (9): pii: e11408.","journal-title":"PLoS One"},{"issue":"1","key":"BFbjc201786_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00330-008-1121-8","volume":"19","author":"N Griffin","year":"2009","unstructured":"Griffin N, Grant LA, Freeman SJ, Jimenez-Linan M, Berman LH, Earl H, Ahmed AA, Crawford R, Brenton J, Sala E (2009) Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique? Eur Radiol 19 (1): 230\u2013235.","journal-title":"Eur Radiol"},{"key":"BFbjc201786_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cjp2.53","volume":"2","author":"M K\u00f6bel","year":"2016","unstructured":"K\u00f6bel M, Piskorz AM, Lee S, Lui S, LePage C, Marass F, Rosenfeld N, Mes Masson A-M, Brenton JD (2016) Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. J Pathol Clin Res 2: 247\u2013258.","journal-title":"J Pathol Clin Res"},{"issue":"5","key":"BFbjc201786_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.amjsurg.2007.01.012","volume":"193","author":"L Lerch","year":"2007","unstructured":"Lerch L, Donald JC, Olivotto IA, Lesperance M, van der Westhuizen N, Rusnak C, Biberdorf D, Ross A, Hayashi A (2007) Measuring surgeon performance of sentinel lymph node biopsy in breast cancer treatment by cumulative sum analysis. Am J Surg 193 (5): 556\u2013559.","journal-title":"Am J Surg"},{"issue":"6","key":"BFbjc201786_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/IGC.0b013e3181dd0110","volume":"20","author":"HJ Mackay","year":"2010","unstructured":"Mackay HJ, Brady MF, Oza AM, Reuss A, Pujade-Lauraine E, Swart AM, Siddiqui N, Colombo N, Bookman MA, Pfisterer J, du Bois A (2010) Prognostic relevance of uncommon ovarian histology in women with stage III\/IV epithelial ovarian cancer. Int J Gynecol Cancer 20 (6): 945\u2013952.","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"BFbjc201786_CR15","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S1470-2045(15)00086-8","volume":"16","author":"AM Oza","year":"2015","unstructured":"Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon T-W, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, Swart AM, Farrelly L, Kaplan R, Parmar MKB, Perren TJ investigators It (2015) Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncol 16 (8): 928\u2013936.","journal-title":"Lancet Oncol"},{"issue":"7553","key":"BFbjc201786_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature14410","volume":"521","author":"A-M Patch","year":"2015","unstructured":"Patch A-M, Christie EL, Etemadmoghadam D, Garsed DW, George J, Fereday S, Nones K, Cowin P, Alsop K, Bailey PJ, Kassahn KS, Newell F, Quinn MCJ, Kazakoff S, Quek K, Wilhelm-Benartzi C, Curry E, Leong HS The Australian Ovarian Cancer Study G Hamilton A, Mileshkin L, Au-Yeung G, Kennedy C, Hung J, Chiew Y-E, Harnett P, Friedlander M, Quinn M, Pyman J, Cordner S, O\/'Brien P, Leditschke J, Young G, Strachan K, Waring P, Azar W, Mitchell C, Traficante N, Hendley J, Thorne H, Shackleton M, Miller DK, Arnau GM, Tothill RW, Holloway TP, Semple T, Harliwong I, Nourse C, Nourbakhsh E, Manning S, Idrisoglu S, Bruxner TJC, Christ AN, Poudel B, Holmes O, Anderson M, Leonard C, Lonie A, Hall N, Wood S, Taylor DF, Xu Q, Fink JL, Waddell N, Drapkin R, Stronach E, Gabra H, Brown R, Jewell A, Nagaraj SH, Markham E, Wilson PJ, Ellul J, McNally O, Doyle MA, Vedururu R, Stewart C, Lengyel E, Pearson JV, Waddell N, deFazio A, Grimmond SM, Bowtell DDL (2015) Whole-genome characterization of chemoresistant ovarian cancer. Nature 521 (7553): 489\u2013494.","journal-title":"Nature"},{"issue":"3","key":"BFbjc201786_CR17","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/annonc\/mdv613","volume":"27","author":"AM Piskorz","year":"2016","unstructured":"Piskorz AM, Ennis D, Macintyre G, Goranova TE, Eldridge M, Segui-Gracia N, Valganon M, Hoyle A, Orange C, Moore L, Jimenez-Linan M, Millan D, McNeish IA, Brenton JD (2016) Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples. Ann Oncol 27 (3): 532\u2013539.","journal-title":"Ann Oncol"},{"issue":"13","key":"BFbjc201786_CR18","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1200\/JCO.2013.51.4489","volume":"32","author":"E Pujade-Lauraine","year":"2014","unstructured":"Pujade-Lauraine E, Hilpert F, Weber B, Reuss A, Poveda A, Kristensen G, Sorio R, Vergote I, Witteveen P, Bamias A, Pereira D, Wimberger P, Oaknin A, Mirza MR, Follana P, Bollag D, Ray-Coquard I (2014) Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA Open-Label Randomized Phase III Trial. J Clin Oncol 32 (13): 1302\u20131308.","journal-title":"J Clin Oncol"},{"issue":"7182","key":"BFbjc201786_CR19","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nature06633","volume":"451","author":"W Sakai","year":"2008","unstructured":"Sakai W, Swisher EM, Karlan BY, Agarwal MK, Higgins J, Friedman C, Villegas E, Jacquemont C, Farrugia DJ, Couch FJ, Urban N, Taniguchi T (2008) Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature 451 (7182): 1116\u20131120.","journal-title":"Nature"},{"issue":"2","key":"BFbjc201786_CR20","doi-asserted-by":"publisher","first-page":"e1001789","DOI":"10.1371\/journal.pmed.1001789","volume":"12","author":"RF Schwarz","year":"2015","unstructured":"Schwarz RF, Ng CK, Cooke SL, Newman S, Temple J, Piskorz AM, Gale D, Sayal K, Murtaza M, Baldwin PJ, Rosenfeld N, Earl HM, Sala E, Jimenez-Linan M, Parkinson CA, Markowetz F, Brenton JD (2015) Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis. PLoS Med 12 (2): e1001789.","journal-title":"PLoS Med"},{"issue":"7","key":"BFbjc201786_CR21","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/annonc\/mdt067","volume":"24","author":"DS Seah","year":"2013","unstructured":"Seah DS, Scott SM, Najita J, Openshaw T, Krag K, Frank E, Sohl J, Stadler ZK, Garrett M, Silverman SG, Peppercorn J, Winer EP, Come SE, Lin NU (2013) Attitudes of patients with metastatic breast cancer toward research biopsies. Ann Oncol 24 (7): 1853\u20131859.","journal-title":"Ann Oncol"},{"key":"BFbjc201786_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1102\/1470-7330.2006.0022","volume":"6","author":"JA Spencer","year":"2006","unstructured":"Spencer JA, Anderson K, Weston M, Wilkinson N, Hewitt M (2006) Image guided biopsy in the management of cancer of the ovary. Cancer Imaging 6: 144\u2013147.","journal-title":"Cancer Imaging"},{"issue":"1","key":"BFbjc201786_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1470-2045(16)30559-9","volume":"18","author":"EM Swisher","year":"2017","unstructured":"Swisher EM, Lin KK, Oza AM, Scott CL, Giordano H, Sun J, Konecny GE, Coleman RL, Tinker AV, O'Malley DM, Kristeleit RS, Ma L, Bell-McGuinn KM, Brenton JD, Cragun JM, Oaknin A, Ray-Coquard I, Harrell MI, Mann E, Kaufmann SH, Floquet A, Leary A, Harding TC, Goble S, Maloney L, Isaacson J, Allen AR, Rolfe L, Yelensky R, Raponi M, McNeish IA (2017) Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. Lancet Oncol 18 (1): 75\u201387.","journal-title":"Lancet Oncol"},{"key":"BFbjc201786_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejca.2016.02.006","volume":"59","author":"V Tacher","year":"2016","unstructured":"Tacher V, Le Deley MC, Hollebecque A, Deschamps F, Vielh P, Hakime A, Ileana E, Abedi-Ardekani B, Charpy C, Massard C, Rosellini S, Gajda D, Celebic A, Ferte C, Ngo-Camus M, Gouissem S, Koubi-Pick V, Andre F, Vassal G, Deandreis D, Lacroix L, Soria JC, De Baere T (2016) Factors associated with success of image-guided tumour biopsies: results from a prospective molecular triage study (MOSCATO-01). Eur J Cancer 59: 79\u201389.","journal-title":"Eur J Cancer"},{"issue":"7353","key":"BFbjc201786_CR25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"TCGA","year":"2011","unstructured":"TCGA (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474 (7353): 609\u2013615.","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1038\/s41416-019-0433-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000}}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc201786.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc201786","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bjc.2017.86","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/bjc201786.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T09:41:51Z","timestamp":1684402911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc201786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,30]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,5,9]]}},"alternative-id":["BFbjc201786"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2017.86","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,30]]},"assertion":[{"value":"19 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}